Latest stories on ALMR
Cathie Wood’s ARK Investment buys 101K shares of Alamar Biosciences today
The Fly63 · neutralgeneral
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
GlobeNewswire50 · neutralearnings
Alamar Biosciences to Report Third Quarter 2026 Financial Results on November 3, 2026
Business Insider50 · neutralearnings
Alamar: The Consumables Flywheel Is Just Getting Started
Seeking Alpha64 · neutralanalyst
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
GlobeNewswire56 · neutralgeneral
Alamar Biosciences Names Former Grail CEO Bob Ragusa to Board of Directors and Expands Leadership Team
Business Insider56 · neutralgeneral
Lancet study using Alamar’s technology reveals divergent responses to Alzheimers
The Fly59 · neutralproduct/pr
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
GlobeNewswire59 · neutralproduct/pr
Lancet Neurology Study Using Alamar Biosciences’ Technology Reveals Divergent Biological Responses to Alzheimer’s Treatment
StockTitan63 · neutralproduct/pr
Why is Alamar Biosciences stock surging today?
Investing.com Markets50 · neutralgeneral
Alamar Biosciences rises 15.1%
The Fly65 · bullishgeneral
Alamar Biosciences rises 9.4%
The Fly58 · neutralgeneral
Why is Alamar Biosciences stock surging today?
Investing.com Markets50 · neutralgeneral
Alamar Biosciences, Inc. (ALMR) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Seeking Alpha56 · neutralproduct/pr
Alamar Biosciences to Participate in Morgan Stanley 24th Annual Global Healthcare Conference
Business Insider56 · neutralgeneral
Alamar Biosciences, Inc. (ALMR) files 8-K
SEC 8-K50 · neutralgeneral
Alamar Biosciences (ALMR) Q2 2026 Earnings Call Transcript
The Motley Fool73 · bullishearnings
Alamar Biosciences: Promising But Expensive Proteomics Growth
Seeking Alpha58 · neutralgeneral
Alamar Biosciences: The Content Flywheel Is More Valuable Than The Instrument
Seeking Alpha73 · bullishproduct/pr
Stifel raises Alamar Biosciences stock price target on earnings beat
Investing.com Analyst Ratings61 · neutralanalyst
Alamar Biosciences price target raised to $31 from $30 at BofA
The Fly61 · neutralanalyst
Alamar Biosciences price target raised to $32 from $28 at Stifel
The Fly63 · neutralanalyst
Alamar Biosciences price target raised to $35 from $32 at JPMorgan
The Fly61 · neutralanalyst
Alamar outlines $116M-$120M 2026 revenue outlook while targeting 100+ instruments and $400,000+ pull-through
Seeking Alpha67 · bullishearnings
Alamar Biosciences, Inc. (ALMR) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings